Changes in clinical stage identify patients with CLL and different outcome within iwCLL partial response: RESONATE study

Br J Haematol. 2019 Apr;185(1):148-150. doi: 10.1111/bjh.15397. Epub 2018 May 31.
No abstract available

Keywords: BTK inhibitor; Binet; chronic lymphocytic leukaemia; ibrutinib; iwCLL.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Bone Marrow / pathology
  • Chromosome Aberrations
  • Clinical Trials, Phase III as Topic
  • Humans
  • Immunoglobulin Heavy Chains / genetics
  • Kaplan-Meier Estimate
  • Leukemia, Lymphocytic, Chronic, B-Cell / diagnosis*
  • Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy
  • Leukemia, Lymphocytic, Chronic, B-Cell / genetics
  • Leukemia, Lymphocytic, Chronic, B-Cell / mortality
  • Middle Aged
  • Neoplasm Staging
  • Patient Outcome Assessment
  • Prognosis

Substances

  • Immunoglobulin Heavy Chains